Editorial
Intraductal Carcinoma of the Prostate as a Window Into PARP Inhibitor Sensitivity
International Journal of Cancer · 03.11.2026
DOI: 10.1002/ijc.70809 ↗Kurz gefasst
Editorial in der Zeitschrift International Journal of Cancer, online erschienen am 03.11.2026. Verfasst von Panagiotis J Vlachostergios. Beteiligte Einrichtung: Department of Medical Oncology, Ioannina University Hospital, Ioannina, Greece. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medical Oncology, Ioannina University Hospital, Ioannina, Greece.
- Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
- Division of Hematology & Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Zitieren
APA
Vlachostergios, P. J. (2026). Intraductal Carcinoma of the Prostate as a Window Into PARP Inhibitor Sensitivity. International Journal of Cancer. https://doi.org/10.1002/ijc.70809
Vancouver
Vlachostergios PJ. Intraductal Carcinoma of the Prostate as a Window Into PARP Inhibitor Sensitivity. International Journal of Cancer. 2026. doi:10.1002/ijc.70809
BibTeX
@article{Vlachostergios2026,
author = {Vlachostergios, Panagiotis J},
title = {Intraductal Carcinoma of the Prostate as a Window Into PARP Inhibitor Sensitivity},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70809}
}
EUVIMED